![Ron Moldaver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Ron Moldaver formerly worked at Cartesian Therapeutics, Inc., as Senior Director-IR & Business Development in 2024 and Editas Medicine, Inc., as Head-Investor Relations from 2020 to 2023.
Former positions of Ron Moldaver
| Companies | Position | End |
|---|---|---|
| EDITAS MEDICINE, INC. | Investor Relations Contact | 01/03/2023 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
- Stock Market
- Insiders
- Ron Moldaver
